Abstract
Background
Lamin proteins A and C are major functional and structural components of the nuclear lamina. Mutations of the LMNA gene have been associated with dilated cardiomyopathy, conduction system defects and skeletal muscle dystrophy simultaneously, in variable involvement. We report on a family with a mutation of the lamin A/C gene (c.908–909delCT).
Methods
Thirty five members of the family of a proband were studied and underwent clinical and genetic evaluation. Family members were considered to be affected if they demonstrated conduction system defects, limb-girdle muscular dystrophy, dilated cardiomyopathy, carried the lamin A/C mutation or suffered sudden death.
Results
Fifteen members of the family were considered to be affected. Conduction system defects were the major feature of the affected members (67%), with variable involvement of dilated cardiomyopathy (33%), and limb-girdle muscular dystrophy (53%). Sudden death occurred in four members (27%) and was the presenting feature in three (20%) of the affected members at an early age. Mutation c.908–909delCT was confirmed in 12 of the affected members. The pattern of inheritance was autosomal dominant.
Conclusion
Lamin c.908–909delCT mutation is malignant compared to other dilated cardiomyopathy—associated mutations of the Lamin A/C gene. Patients with this mutation have rapid progression of atrioventricular conduction abnormalities, and sudden death may be the presenting feature. Early identification of affected families and consideration of an implantable defibrillator is important in this setting.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mounkes, L. C., Burke, B., & Stewart, C. L. (2001). The A-type lamins; Nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases. Trends in Cardiovascular Medicine, 11, 280–285.
Stuurman, N., Heins, S., & Aebi, U. (1998). Nuclear lamins: Their structure, assembly and interactions. Journal of Structural Biology, 122, 32–46.
Franz, W. M., Muller, O. J., & Katus, H. A. (2001). Cardiomyopathies: From genetics to the prospect of treatment. Lancet, 358, 1627–1637.
Holmer, L., & Worman, H. J. (2001). Inner nuclear membrane proteins: Functions and targeting. Cellular and Molecular Life Sciences, 58, 1741–1747.
Taylor, M. R., Fain, P. R., Sinagra, G., Robinson, M. L., Robertson, A. D., Carniel, E., et al. (2003). Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. Journal of the American College of Cardiology, 41, 771–780.
Schonberrger, J., & Seidman, C. (2001). Many roads lead to a broken heart: The genetics of dilated cardiomyopathy. American Journal of Human Genetics, 69, 249–260.
Karkkainen, S., Helio, T., Miettinen, R., Tuomainen, P., Peltola, P., Rummukainen, J., et al. (2004). A novel mutation, Ser143Pro, in the lamin A/C gene is common in Finnish patients with familial dilated cardiomyopathy. European Heart Journal, 25, 885–893.
MacLeod, H. M., Culley, M. R., Huber, J. M., & McNally, E. M. (2003). Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC Medical Genetics, 4, 4.
Atherton, J., Vidaillet, H. J. Jr, Spudich, S., De Girolami, U., Seidman, J. G., Seidman, C., et al. (1999). Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. New England Journal of Medicine, 341, 1715–1724.
Jacobs, P. M., Hanson, E. L., Crispel, K. A., Toy, W., Keegan, H., Schilling, K., et al. (2001). Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. Journal of Cardiac Failure, 3, 249–256.
Tomaso, S., Antonio, R., Toniolo, D., Vytopil, M., Pelargonio, G., Martino, G. D., et al. (2003). Cardiac features of Emery–Dreiafus muscular dystrophy caused by lamin A/C gene mutations. European Heart Journal, 24, 2227–2236.
Hong, J. S., Ki, C. S., Kim, J. W., Suh, Y. L., Kim, J. S., Baek, K. K., et al. (2005). Cardiac dysrhythmias, cardiomyopathy and muscular dystrophy in patients with Emery–Dreifuss muscular dystrophy and limb-girdle muscular dystrophy type 1B. Journal of Korean Medical Science, 20, 283–290.
Muchir, A., Bonne, G., van der Kooi, A. J., van Meegen, M., Baas, F., Bolhuis, P. A., et al. (2000). dentification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMB IB). Human Molecular Genetics, 9, 1453–1459.
De Sandre-Giovannoli, A., Chaouch, M., Kozlov, S., Vallat, J. M., Tazir, M., Kassouri, et al. (2002). Homozygous defects in LMNA, encoding lamin A/C nuclear-envelop proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. American Journal of Human Genetics, 70, 726–736.
Van Berlo, J. H., de Voogt, W. C., van der Kooi, A. J., van Tintelen, J. P., Bonne, G., Yaou, R. B., et al. (2005). Meta-analysis of clinical characteristics 0f 299 carriers of LMNA gene mutations: Do lamin A/C mutations portend a high risk for sudden death? Journal of Molecular Medecine, 83, 79–83.
Meune, C., Van Berlo, J. H., Anselme, F., Bonne, G., Pinto, Y. M., & Duboc, D. (2006). Primary prevention of sudden death in patients with lamin A/C gene mutations. New England Journal of Medicine, 354, 209–210.
Gardin, J. M., Adams, D. B., Douglas, R. S., Feigenbaum, H., Forst, D. H., Fraser, A. G., et al. (2002). Recommendations for a standardized report for adult transthoracic echocardiography: A report from the American Society of Echocardiography’s. Nomenclature and standards Committee and Task Force for a Standardized Echocardiographic Report. Journal of the American Society of Echocardiography, 15, 275–290.
Mestroni, L., Maisch, B., McKenna, W. J., Schwartz, K., Charron, P., Rocco, C., et al. (1999). Guidelines for the study of familial dilated Cardiomyopathies. European Heart Journal, 20, 93–102.
Bushby, K. M. (1995). Diagnostic criteria for the limb-girdle muscular dystrophies: Report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscular Disorders, 5, 71–74.
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
Christodoulou, K., Kyriakides, T., Hristova, A. H., Georgiou, D. M., Kalaydjieva, L., Yshpekova, B., et al. (1995). Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Human Molecular Genetics, 4, 1629–1632.
Lathrop, G. M., Lalouel, J. M., Julier, C., & Ott, J. (1985). Multilocus linkage analysis in humans: Detection of linkage and estimation of recombination. American Journal of Human Genetics, 37, 482–498.
Hutchison, C. J., Alvarez-Reyes, M., & Vaughan, O. A. (2001). Lamins in disease: Why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? Journal of Cell Science, 114(pt1), 9–19.
Sebillon, P., Bouchier, C., Bidot, L. D., Bonne, G., Ahamed, K., Charron, P., et al. (2003). Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. Journal of Medical Genetics, 40, 560–567.
Charniot, J. C., Desnos, M., Zerhouni, K., Bonnefont-Rousselot, D., Albertini, J. P., Salama, J. Z., et al. (2006). Severe dilated cardiomyopathy and quadriceps myopathy due to lamin A/C gene mutation: A phenotypic study. European Journal of Heart Failure, 8, 249–256.
Brodsky, G. L., Muntoni, F., Miocic, S., Sinagra, G., Sewry, C., & Mestroni, L. (2000). Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation, 101, 473–476.
Kirschner, J., & Bonnemann, C. G. (2004). The congenital and limb-girdle muscular dystrophies: Sharpening the focus, blurring the boundaries. Archives of Neurology, 61, 189–199.
Ki, C. S., Hong, J. S., Jeong, G. Y., Ahn, K. J., Choi, K. M., Kim, D. K., et al. (2002). Identification of lamin A/C (LMNA) gene mutations in Korean patients with autosomal dominant Emery–Dreifuss muscular dystrophy and limb-girdle muscular dystrophy 1B. Journal of Human Genetics, 47(5), 225–228.
Bon, Y. R., Became, H. M., Demay, L., Laforet, P., Hannequin, D., Bohu, P. A., et al. (2005). Autosomal dominant limb-girdle muscular dystrophy (LGMD 1B); A description of 8 new families with the LMNA mutations. Revue Neurologique (Paris), 161, 42–54.
Van Berlo, J., Duboc, D., Pinto, Y. (2004). Often seen but rarely recognized: Cardiac complications of lamin A/C mutations. European Heart Journal, 25, 812–814.
Becane, M.-H., Bonne, G., Varnous, S., Muchir, A., et al. (2000). High incidence of sudden death with conduction system and myocardial disease due to Lamins A and C gene mutations. Pace, 23, 1661–1666.
ACC/AHA/ESC (2006). Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary. Journal of the American College of Cardiology, 48, 1064–1108.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Muscular Dystrophy Association of the USA (grant to Drs Theodoros Kyriakides and Kyproula Christodoulou).
Rights and permissions
About this article
Cite this article
Antoniades, L., Eftychiou, C., Kyriakides, T. et al. Malignant mutation in the lamin A/C gene causing progressive conduction system disease and early sudden death in a family with mild form of limb-girdle muscular dystrophy. J Interv Card Electrophysiol 19, 1–7 (2007). https://doi.org/10.1007/s10840-007-9133-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-007-9133-x